Ajanta Pharma Q1 net profit rises 18% to Rs 246 crore
The companys US sales grew 7 per cent to Rs 228 crore in the first quarter of the current fiscal.Shares of Ajanta Pharma ended 3.99 per cent up at Rs 2,524.35 apiece on the BSE.
Ajanta Pharma on Tuesday said its consolidated profit after tax (PAT) increased 18 per cent year-on-year to Rs 246 crore for the June quarter, on account of robust sales across domestic and international markets.
The drug firm had reported a profit after tax of Rs 208 crore in the April-June quarter of last fiscal.
Revenue from operations rose to Rs 1,145 crore during the quarter under review as against Rs 1,021 crore in the year-go period, Ajanta Pharma said in a regulatory filing.The company said its India sales grew 10 per cent year-on-year to Rs 353 crore in the first quarter.
The company's US sales grew 7 per cent to Rs 228 crore in the first quarter of the current fiscal.Shares of Ajanta Pharma ended 3.99 per cent up at Rs 2,524.35 apiece on the BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.